223 related articles for article (PubMed ID: 31546735)
21. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
22. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
23. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
24. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139
[TBL] [Abstract][Full Text] [Related]
25. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
26. β-Catenin/Smad3 Interaction Regulates Transforming Growth Factor-β-Induced Epithelial to Mesenchymal Transition in the Lens.
Taiyab A; Holms J; West-Mays JA
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035577
[TBL] [Abstract][Full Text] [Related]
27. TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells.
Wang T; Zhang L; Shi C; Sun H; Wang J; Li R; Zou Z; Ran X; Su Y
Int J Biochem Cell Biol; 2012 Feb; 44(2):366-76. PubMed ID: 22119803
[TBL] [Abstract][Full Text] [Related]
28. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
30. In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients.
Petanidis S; Kioseoglou E; Domvri K; Zarogoulidis P; Carthy JM; Anestakis D; Moustakas A; Salifoglou A
Int J Biochem Cell Biol; 2016 May; 74():121-34. PubMed ID: 26916505
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.
Leonel C; Borin TF; de Carvalho Ferreira L; Moschetta MG; Bajgelman MC; Viloria-Petit AM; de Campos Zuccari DA
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):27-41. PubMed ID: 28078601
[TBL] [Abstract][Full Text] [Related]
32. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
34. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
[TBL] [Abstract][Full Text] [Related]
35. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
36. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
Ouanouki A; Lamy S; Annabi B
Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
[TBL] [Abstract][Full Text] [Related]
38. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
39. TGF-β-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma.
Miyashita N; Enokido T; Horie M; Fukuda K; Urushiyama H; Strell C; Brunnström H; Micke P; Saito A; Nagase T
Sci Rep; 2021 Nov; 11(1):22380. PubMed ID: 34789779
[TBL] [Abstract][Full Text] [Related]
40. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells.
Ratz L; Laible M; Kacprzyk LA; Wittig-Blaich SM; Tolstov Y; Duensing S; Altevogt P; Klauck SM; Sültmann H
Oncotarget; 2017 Apr; 8(15):25115-25130. PubMed ID: 28445989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]